Last10K.com

Celularity Inc (CELU) SEC Filing 8-K Material Event for the period ending Tuesday, March 14, 2023

Celularity Inc

HISTORY TOOLS
CIK: 1752828 Ticker: CELU

View differences made from one to another to evaluate Celularity Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Celularity Inc.

Continue

Assess how Celularity Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Celularity Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information
Ticker: CELU
CIK: 1752828
Form Type: 8-K Corporate News
Accession Number: 0000950170-23-008662
Submitted to the SEC: Fri Mar 17 2023 5:17:55 PM EST
Accepted by the SEC: Fri Mar 17 2023
Period: Tuesday, March 14, 2023
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/celu/0000950170-23-008662.htm